Celltrion Nasdaq

SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...

South Korea’s SK Hynix Inc. decided to list the recently acquired Intel Corp.’s NAND flash memory chip business on the Nasdaq in a move ...

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...

South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...

FiscalNote Holdings Inc., a US legal data and analytics company founded by a Korean-American, is set to go public in a deal valued at $1.3 billion. ...

South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...

South Korean millennials in their 20s and 30s are rushing to Nasdaq and the New York Stock Exchange (NYSE) amid skyrocketing real estate prices in t...

South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...

South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...

South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...

South Korea's largest travel platform Yanolja has raised 2 trillion won ($1.7 billion) from the Masayoshi Son-led SoftBank Vision Fund II, marking t...

Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...

South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...

South Korea’s SK Innovation Co. said on Thursday it is considering a spin-off of its battery business and listing the separated entity on the ...

SK Group has pledged to achieve carbon neutrality prior to 2050, the year set by the United Nations (UN) to reach net-zero carbon emissions globally...

Nano-X Imaging Ltd. (Nanox), an Israeli startup listed on the Nasdaq last August, has started manufacturing digital X-ray components in South Korea....

South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...

Teamblind Inc., the operator of Blind, an anonymous social platform for discussion on workplace issues, has successfully concluded its $37 million S...

South Korea’s National Pension Service (NPS), other state-run savings funds and big companies are expected to pocket decent gains from their...

DoubleDown Interactive LLC, a South Korean social casino game publisher, has resumed its Nasdaq listing process, tapping the red-hot US IPO market w...

South Korea’s largest travel platform Yanolja’s enterprise value could rise to at least $11 billion if the stock is listed on the Nasdaq...

South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...

Celltrion Inc. and HLB Inc., two leading South Korean biopharmaceutical shares, shot up on Monday as the main bourse’s key index climbed back ...

South Korea’s e-commerce giant Coupang Corp. has received the green light for its Nasdaq listing, increasing the possibility of a trading ...

South Korea’s leading e-commerce giant Coupang Corp. is preparing for a trading debut on the Nasdaq in the second quarter, by which the compan...

South Korean bourses on Wednesday wrapped up this year's trade at their highest levels of the year, rising the most among major equity markets and b...

South Korea's Celltrion Inc. has completed second-phase clinical trials of its COVID-19 treatment and is seeking conditional approval of its distr...

Bespin Global, a South Korean cloud technology consulting and management company, is considering listing its shares on the US tech-heavy Nasdaq mark...